AYTU BIOPHARMA, INC Quarterly Depreciation, Depletion and Amortization in USD from Q3 2014 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Aytu Biopharma, Inc annual/quarterly Depreciation, Depletion and Amortization history and growth rate from Q3 2014 to Q3 2023.
  • Aytu Biopharma, Inc Depreciation, Depletion and Amortization for the quarter ending September 30, 2023 was $2.23M, a 3.09% decline year-over-year.
  • Aytu Biopharma, Inc annual Depreciation, Depletion and Amortization for 2024 was $8.27M, a 6.16% decline from 2023.
  • Aytu Biopharma, Inc annual Depreciation, Depletion and Amortization for 2023 was $8.82M, a 13.1% decline from 2022.
  • Aytu Biopharma, Inc annual Depreciation, Depletion and Amortization for 2022 was $10.1M, a 10.3% increase from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $2.23M -$71K -3.09% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q3 2022 $2.3M -$376K -14% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q3 2021 $2.68M +$642K +31.5% Jul 1, 2021 Sep 30, 2021 10-Q/A 2023-02-21
Q3 2020 $2.04M +$1.17M +134% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q3 2019 $869K +$313K +56.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q3 2018 $557K -$96.5K -14.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q3 2017 $653K -$169K -20.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q3 2016 $822K +$693K +537% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q3 2015 $129K +$104K +425% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q3 2014 $24.6K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.